Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study-Reference-Cited by-同舟云学术

Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study

Published:2019-12 Issue:51 Volume:37 Page:7482-7492
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Hammitt Laura L.^ORCID,Campbell James C.,Borys Dorota,Weatherholtz Robert C.,Reid Raymond,Goklish Novalene,Moulton Lawrence H.,Traskine Magali,Song Yue,Swinnen Kristien,Santosham Mathuram,O'Brien Katherine L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference47 articles.

1. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15;Wahl;Lancet Glob Health,2018

2. IVAC. VIEW-hub. 2017; http://view-hub.org/. Accessed July 25, 2017.

3. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population;Cortese;Arch Intern Med,1992

4. The epidemiology of invasive pneumococcal disease in Alaska, 1986–1990–ethnic differences and opportunities for prevention;Davidson;J Infect Dis,1994

5. Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases;O'Brien;Am J Epidemiol,2004

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDENTIFYING PLAUSIBLE RANGES FOR DIFFERENTIAL VACCINE EFFICACY ACROSS HIGH- AND LOW-INCOME SETTINGS: A SYSTEMATIC REVIEW, DESCRIPTIVE META-ANALYSIS, AND ILLUSTRATIVE EVIDENCE ANALYSIS;2024-08-01

2. Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study;Vaccines;2024-07-23

3. Serological Profiling of Pneumococcal Proteins Reveals Unique Patterns of Acquisition, Maintenance, and Waning of Antibodies Throughout Life;The Journal of Infectious Diseases;2024-04-29

4. Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study;Vaccine;2024-02

5. ISOM 2023 Research Panel 5: Interventions- Vaccines and prevention, medical and surgical treatment, and impact of COVID-19 pandemic;International Journal of Pediatric Otorhinolaryngology;2024-01